CA2150033A1 - Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer - Google Patents

Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer

Info

Publication number
CA2150033A1
CA2150033A1 CA002150033A CA2150033A CA2150033A1 CA 2150033 A1 CA2150033 A1 CA 2150033A1 CA 002150033 A CA002150033 A CA 002150033A CA 2150033 A CA2150033 A CA 2150033A CA 2150033 A1 CA2150033 A1 CA 2150033A1
Authority
CA
Canada
Prior art keywords
asa
acetylsalicylic acid
application system
skin
transdermal application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002150033A
Other languages
English (en)
French (fr)
Inventor
Frank Becher
Thomas Kissel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/de
Application filed by Individual filed Critical Individual
Publication of CA2150033A1 publication Critical patent/CA2150033A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002150033A 1992-12-07 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer Abandoned CA2150033A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4241128.9 1992-12-07
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält

Publications (1)

Publication Number Publication Date
CA2150033A1 true CA2150033A1 (en) 1994-06-23

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002150033A Abandoned CA2150033A1 (en) 1992-12-07 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer

Country Status (14)

Country Link
EP (1) EP0671916A1 (fi)
JP (1) JP3799502B2 (fi)
AU (1) AU694410B2 (fi)
CA (1) CA2150033A1 (fi)
CZ (1) CZ149495A3 (fi)
FI (1) FI120719B (fi)
HR (1) HRP931474A2 (fi)
HU (1) HUT75680A (fi)
IL (1) IL107867A (fi)
NO (1) NO952234D0 (fi)
NZ (1) NZ258129A (fi)
PL (1) PL174770B1 (fi)
SK (1) SK75495A3 (fi)
ZA (1) ZA939126B (fi)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1738623A (zh) * 2003-01-23 2006-02-22 夏尔控股公司 治疗血小板增多症的制剂和方法
EP1716854A4 (en) 2004-02-16 2010-01-20 Teikoku Seiyaku Kk EXTERNAL PREPARATION FOR TREATING PAINFUL SKIN WOUNDS
JP6720257B2 (ja) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count

Also Published As

Publication number Publication date
FI952805A0 (fi) 1995-06-07
IL107867A0 (en) 1994-04-12
AU5563294A (en) 1994-07-04
NO952234L (no) 1995-06-06
NO952234D0 (no) 1995-06-06
PL309285A1 (en) 1995-10-02
NZ258129A (en) 1999-10-28
AU694410B2 (en) 1998-07-23
HU9501641D0 (en) 1995-08-28
EP0671916A1 (de) 1995-09-20
HUT75680A (en) 1997-05-28
SK75495A3 (en) 1996-05-08
ZA939126B (en) 1994-08-05
FI952805A (fi) 1995-06-07
FI120719B (fi) 2010-02-15
PL174770B1 (pl) 1998-09-30
JP3799502B2 (ja) 2006-07-19
CZ149495A3 (en) 1996-03-13
IL107867A (en) 1998-08-16
JPH08504198A (ja) 1996-05-07
HRP931474A2 (en) 1994-12-31

Similar Documents

Publication Publication Date Title
US6264978B1 (en) Transdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis
US5662925A (en) Transdermal delivery system with adhesive overlay and peel seal disc
US5122383A (en) Sorbitan esters as skin permeation enhancers
US5227169A (en) Sorbitan esters as skin permeation enhancers
NZ306429A (en) transdermal system containing a matrix of polyisobutane or butyl rubber and an angiotensin converting enzyme inhibitor
JPS6049601B2 (ja) 治療デバイス
US5212199A (en) Sorbitan esters as skin permeation enhancers
US4788064A (en) Transdermal delivery system
JP4938949B2 (ja) アセチルサリチル酸および／またはサリチル酸投与用の経皮治療システム
CA2150033A1 (en) Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
JPS639546Y2 (fi)
WO1997004758A1 (en) Pharmaceutical preparation for percutaneous absorbtion
SI9400023A (sl) Transdermalni sistem dajanja, vsebujoč acetilsalicilno kislino za antitrombotsko terapijo in profilakso proti raku
KR19980027318A (ko) 비스테로이드성 소염진통제를 함유하는 경피흡수제제와 그의 제조방법
IE960539A1 (en) Pharmaceutical preparation for percutaneous absorbtion
MXPA97004291A (en) System of release transdermica conrecubrimiento adhesivo and disco de selladodesprendi

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20021118